Alphyn Secures FDA Clearance of Investigational New Drug Application for Atopic Dermatitis Treatment
Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New ...
Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic dermatitis and delves into each option ...
Dry skin between fingers may be because of your skincare product. It may also be due to a skin condition called dyshidrotic ...
"Eczema is a condition that causes patches of skin to become ... and immunologic factors that contribute to this condition," ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results